International Prospective Registry on Local Treatment Approaches in MLS

International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)

In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches.

Inclusion Criteria:

• Age > 18 years
• Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
• ECOG PS 0-2
• Written informed consent to share coded information in this international Registry

Exclusion Criteria:

• Prior radiotherapy to the target area
• Pregnancy